1. 2020: Alarcón-Sánchez BR, Guerrero-Escalera D, Rosas-Madrigal S, Ivette Aparicio-Bautista D, Reyes-Gordillo K, Lakshman MR, Ortiz-Fernández A, Quezada H, Medina-Contreras Ó, Villa-Treviño S, Isael Pérez-Carreón JI, Arellanes-Robledo J. Nucleoredoxin interaction with flightless-I/actin complex is differentially altered in alcoholic liver disease. Basic Clin Pharmacol Toxicol. 2020 Nov;127(5):389-404. doi: 10.1111/bcpt.13451. Factor de Impacto: 2.7
2. 2021: Arellanes-Robledo J, Ibrahim J, Reyes-Gordillo K, Shah R, Leckey L, Lakshman MR. Flightless-I is a potential biomarker for the early detection of alcoholic liver disease. Biochem Pharmacol. 2021 Jan;183:114323. doi: 10.1016/j.bcp.2020.114323. Factor de Impacto: 5.3
3. 2021: Castro-Gil MP, Sánchez-Rodríguez R, Torres-Mena JE, López-Torres CD, Quintanar-Jurado V, Gabiño-López NB, Villa-Treviño S, Del-Pozo-Yauner L, Arellanes-Robledo J, Pérez-Carreón JI. Enrichment of progenitor cells by 2-acetylaminofluorene accelerates liver carcinogenesis induced by diethylnitrosamine in vivo. Mol Carcinog. 2021 Mar 25. doi: 10.1002/mc.23298. Factor de Impacto: 3.0
4. 2021: Adhikari R, Shah R, Reyes-Gordillo K, Arellanes-Robledo J, Cheng Y, Ibrahim J, Tuma PL. Spermidine Prevents Ethanol and Lipopolysaccharide-Induced Hepatic Injury in Mice. Molecules. 2021 Mar 22;26(6):1786. doi: 10.3390/molecules26061786. Factor de Impacto: 4.2
5. 2021: Velázquez-Enríquez JM, Santos-Álvarez JC, Ramírez-Hernández AA, Reyes-Jiménez E, López-Martínez A, Pina-Canseco S, Aguilar-Ruiz SR, Romero-Tlalolini MLÁ, Castro-Sánchez L, Arellanes-Robledo J, Vásquez-Garzón VR, Baltiérrez-Hoyos R. Proteomic Analysis Reveals Key Proteins in Extracellular Vesicles Cargo Associated with Idiopathic Pulmonary Fibrosis In Vitro. Biomedicines. 2021 Aug 20;9(8):1058. doi: 10.3390/biomedicines9081058. Factor de Impacto: 3.9
6. 2021: Alarcón-Sánchez BR, Pérez-Carreón JI, Villa-Treviño S, Arellanes-Robledo J. Molecular alterations that precede the establishment of the hallmarks of cancer: An approach on the prevention of hepatocarcinogenesis. Biochem Pharmacol. 2021 Dec;194:114818. doi: 10.1016/j.bcp.2021.114818. Factor de Impacto: 5.3
7. 2021: Moreno-García DM, Zepeda-Bastida A, Ocampo-López J, Alarcón-Sánchez BR, Idelfonso-García OG, Rosas-Madrigal S, Aparicio-Bautista DI, Pérez-Carreón JI, Villa-Treviño S, Arellanes-Robledo J. Aqueous extracts from Tenebrio molitor larval and pupal stages inhibit early hepatocarcinogenesis in vivo. J Zhejiang Univ Sci B. 2021 Dec 15;22(12):1045-1052. doi: 10.1631/jzus.B2100201. Factor de Impacto: 4.7
8. 2022: Márquez-Quiroga LV, Arellanes-Robledo J, Vásquez-Garzón VR, Villa-Treviño S, Muriel P. Models of nonalcoholic steatohepatitis potentiated by chemical inducers leading to hepatocellular carcinoma. Biochem Pharmacol. 2022 195:114845. doi: 10.1016/j.bcp.2021.114845. Factor de Impacto: 5.3
9. 2022: Castro-Gil MP, Torres-Mena JE, Salgado RM, Muñoz-Montero SA, Martínez-Garcés JM, Lopez-Torres CD, Mendoza-Vargas A, Gabiño-López NB, Villa-Treviño S, Del Pozo-Yauner L, Arellanes-Robledo J, Krötzsch E, Pérez-Carreón JI. The transcriptome of early GGT/KRT19-positive hepatocellular carcinoma reveals a downregulated gene expression profile associated with fatty acid metabolism. Genomics. 2022 Jan;114(1):72-83. doi: 10.1016/j.ygeno.2021.11.035. Factor de Impacto: 3.4
10. 2022: Guerrero-Escalera D, Alarcón-Sánchez BR, Arellanes-Robledo J, Cruz-Rangel A, Del Pozo-Yauner L, Chagoya-Hazas V, Resendis-Antonio O, Villa-Treviño S, Torres-Mena JE, Pérez-Carreón JI. Comparative subcellular localization of NRF2 and KEAP1 during the hepatocellular carcinoma development in vivo. Biochim Biophys Acta Mol Cell Res. 2022 May;1869(5):119222. doi: 10.1016/j.bbamcr.2022.119222. Factor de Impacto: 4.6
11. 2022: Reyes-Avendaño I, Reyes-Jiménez E, González-García K, Pérez-Figueroa DC, Baltiérrez-Hoyos R, Tapia-Pastrana G, Sánchez-Chino XM, Villa-Treviño S, Arellanes-Robledo J, Vásquez-Garzón VR. Quercetin regulates key components of the cellular microenvironment during early hepatocarcinogenesis. Antioxidants (Basel). 2022 Feb 11;11(2):358. doi: 10.3390/antiox11020358. Factor de Impacto: 6.0
12. 2022: Santos-Álvarez JC, Velázquez-Enríquez JM, García-Carrillo R, Rodríguez-Beas C, Ramírez-Hernández AA, Reyes-Jiménez E, González-García K, López-Martínez A, Pérez-Campos Mayoral L, Aguilar-Ruiz SR, Romero-Tlalolini MLÁ, Torres-Aguilar H, Castro-Sánchez L, Arellanes-Robledo J, Vásquez-Garzón VR, Baltiérrez-Hoyos R. miRNAs Contained in Extracellular Vesicles Cargo Contribute to the Progression of Idiopathic Pulmonary Fibrosis: An In Vitro Aproach. Cells. 2022 Mar 25;11(7):1112. doi: 10.3390/cells11071112. Factor de Impacto: 5.1
13. 2022: Aparicio-Bautista DI, Chávez-Valenzuela D, Ambriz-Álvarez G, Córdova-Fraga T, Reyes-Grajeda JP, Medina-Contreras Ó, Rodríguez-Cruz F, García-Sierra F, Zúñiga-Sánchez P, Gutiérrez-Gutiérrez AM, Arellanes-Robledo J, Basurto-Islas G. An Extremely Low-Frequency Vortex Magnetic Field Modifies Protein Expression, Rearranges the Cytoskeleton, and Induces Apoptosis of a Human Neuroblastoma Cell Line. Bioelectromagnetics. 2022 May;43(4):225-244. doi: 10.1002/bem.22400. Factor de Impacto: 1.8
14. 2022: Idelfonso-García OG, Alarcón-Sánchez BR, Vásquez-Garzón VR, Baltiérrez-Hoyos R, Villa-Treviño S, Muriel P, Serrano H, Pérez-Carreón JI, Arellanes-Robledo J. Is Nucleoredoxin a Master Regulator of Cellular Redox Homeostasis? Its Implication in Different Pathologies. Antioxidants (Basel). 2022 Mar 30;11(4):670. doi: 10.3390/antiox11040670. Factor de Impacto: 6.0
15. 2022: López-Torres CD, Torres-Mena JE, Castro-Gil MP, Villa-Treviño S, Arellanes-Robledo J, Del Pozo-Yauner L, Pérez-Carreón JI. Downregulation of indolethylamine N-methyltransferase is an early event in the rat hepatocarcinogenesis and is associated with poor prognosis in hepatocellular carcinoma patients. J Gene Med. 2022 Aug;24(8):e3439. doi: 10.1002/jgm.3439. Factor de Impacto: 3.2
16. 2022: Vargas-Pozada EE, Ramos-Tovar E, Rodriguez-Callejas JD, Cardoso-Lezama I, Galindo-Gómez S, Talamás-Lara D, Vásquez-Garzón VR, Arellanes-Robledo J, Tsutsumi V, Villa-Treviño S, Muriel P. Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB Signaling Pathway in an Experimental NASH Model. Int J Mol Sci. 2022 Sep 1;23(17):9954. doi: 10.3390/ijms23179954. Factor de Impacto: 4.9
17. 2022: González-Garrido A, Rosas-Madrigal S, Rojo-Domínguez A, Arellanes-Robledo J, López-Mora E, Carnevale A, Arregui L, Rosendo-Gutiérrez R, Romero-Hidalgo S, Villarreal-Molina MT. Leukocyte Nuclear Morphology Alterations in Dilated Cardiomyopathy Caused by a Lamin AC Truncating Mutation (LMNA/Ser431*) Are Modified by the Presence of a LAP2 Missense Polymorphism (TMPO/Arg690Cys). Int J Mol Sci. 2022 Nov 7;23(21):13626. doi: 10.3390/ijms232113626. Factor de Impacto: 4.9
18. 2023: Vargas-Pozada EE, Ramos-Tovar E, Rodriguez-Callejas JD, Cardoso-Lezama I, Galindo-Gómez S, Gil-Becerril K, Vásquez-Garzón VR, Arellanes-Robledo J, Tsutsumi V, Villa-Treviño S, Muriel P. Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASH. Ann Hepatol. 2023 Jan-Feb;28(1):100780. doi: 10.1016/j.aohep.2022.100780. Factor de Impacto: 3.7
19. 2023: Herrera-López EE, Guerrero-Escalera D, Aguirre-Maldonado I, López-Hernández A, Montero H, Gutiérrez-Nava MA, Del Pozo-Yauner L, Arellanes-Robledo J, Camacho J, Pérez-Carreón JI. Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis. Sci Rep. 2023 Apr 28;13(1):6948. doi: 10.1038/s41598-023-34117-8. Factor de Impacto: 3.8
20. 2023: Cardoso-Lezama I, Fuentes-Figueroa MÁ, Ramos-Tovar E, Márquez-Quiroga LV, Ortiz-Fernández A, Vargas-Pozada EE, Arellanes-Robledo J, Tsutsumi V, Muriel P. Nicotinic acid attenuates experimental non-alcoholic steatohepatitis by inhibiting the NLRP3 inflammasome/pyroptosis pathway. Biochem Pharmacol. 2023 Oct;216:115762. doi: 10.1016/j.bcp.2023.115762. Factor de Impacto: 5.3
21. 2024: Cardoso-Lezama I, Ramos-Tovar E, Arellanes-Robledo J, Vargas-Pozada EE, Vásquez-Garzón VR, Villa-Treviño S, Muriel P. Serum α-SMA is a potential noninvasive biomarker of liver fibrosis. Toxicol Mech Methods. 2024 Jan;34(1):13-19. doi: 10.1080/15376516.2023.2244061. Factor de Impacto: 2.8
22. 2024: Zertuche-Martínez C, Velázquez-Enríquez JM, González-García K, Baltiérrez-Hoyos R, Carrasco-Torres G, García-Román R, Romero-Díaz RI, Pérez-Hernández JL, Muriel P, Villa-Treviño S, Arellanes-Robledo J, Vásquez-Garzón VR. Identification of ABCC3 and its isoforms as potential biomarker in hepatocellular carcinoma. Toxicol Mech Methods. 2024 May;34(4):398-407. doi: 10.1080/15376516.2023.2294475. Factor de Impacto: 2.8
23. 2024: Idelfonso-García OG, Alarcón-Sánchez BR, Guerrero-Escalera D, López-Hernández NA, Pérez-Hernández JL, Pacheco-Rivera R, Serrano-Luna J, Resendis-Antonio O, Muciño-Olmos EA, Aparicio-Bautista DI, Basurto-Islas G, Baltiérrez-Hoyos R, Vásquez-Garzón VR, Villa-Treviño S, Muriel P, Serrano H, Pérez-Carreón JI, Arellanes-Robledo J. Nucleoredoxin Redox Interactions Are Sensitized by Aging and Potentiated by Chronic Alcohol Consumption in the Mouse Liver. Antioxidants (Basel). 2024 Feb 20;13(3):257. doi: 10.3390/antiox13030257. Factor de Impacto: 6.0
24. 2024: Hernández-Galdámez HV, Fattel-Fazenda S, Flores-Téllez TNJ, Aguilar-Chaparro MA, Mendoza-García J, Díaz-Fernández LC, Romo-Medina E, Sánchez-Pérez Y, Arellanes-Robledo J, De la Garza M, Villa-Treviño S, Piña-Vázquez C. Iron-saturated bovine lactoferrin: a promising chemopreventive agent for hepatocellular carcinoma. Food Funct. 2024 Apr 9. doi: 10.1039/d3fo05184f. Epub ahead of print. PMID: 38590223. Factor de Impacto: 5.1
25. 2024: Idelfonso-García OG, Pacheco-Rivera R, Alarcón-Sánchez BR, Serrano-Luna J, Baltiérrez-Hoyos R, Vásquez-Garzón VR, Muriel P, Villa-Treviño S, Pérez-Carreón JI, Arellanes-Robledo J. Protocol to detect senescence-associated β-galactosidase and immunoperoxidase activity in fresh-frozen murine tissues. STAR Protoc. 2024 Apr 10;5(2):103009. doi: 10.1016/j.xpro.2024.103009. Epub ahead of print. PMID: 38602869. Factor de Impacto: 1.3
26. 2024: Alarcón-Sánchez BR, Idelfonso-García OG, Guerrero-Escalera D, Piña-Vázquez C, de Anda-Jáuregui G, Pérez-Hernández JL, de la Garza M, García-Sierra F, Sánchez-Pérez Y, Baltiérrez-Hoyos R, Vásquez-Garzón VR, Muriel P, Pérez-Carreón JI, Villa-Treviño S, Arellanes-Robledo J. A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer. Biochem Pharmacol. 2024 Apr 16:116209. doi: 10.1016/j.bcp.2024.116209. Factor de Impacto: 5.3
27. 2024: Reyes-Avendaño I, Villaseñor-Altamirano AB, Reyes-Jiménez E, Velázquez-Enríquez JM, Baltiérrez-Hoyos R, Piña-Vázquez C, Muriel P, Villa-Treviño S, Arellanes-Robledo J, Vásquez-Garzón VR. Identification of key markers for the stages of nonalcoholic fatty liver disease: An integrated bioinformatics analysis and experimental validation. Dig Liver Dis. 2024 May 31:S1590-8658(24)00767-9. doi: 10.1016/j.dld.2024.05.010. Factor de Impacto: 4.0
28. 2024: Zertuche-Martínez C, Velázquez-Enríquez JM, González-García K, Santos-Álvarez JC, Romero-Tlalolini MLÁ, Pina-Canseco S, Pérez-Campos Mayoral L, Muriel P, Villa-Treviño S, Baltiérrez-Hoyos R, Arellanes-Robledo J, Vásquez-Garzón VR. Discovery of candidate biomarkers from plasma-derived extracellular vesicles of patients with cirrhosis and hepatocellular carcinoma: an exploratory proteomic study. Mol Omics. 2024 Jul 16. doi: 10.1039/d4mo00043a. Factor de Impacto: 3.0
29. 2024: Velázquez-Enríquez JM, Santos-Álvarez JC, Ramírez-Hernández AA, Reyes-Jiménez E, Pérez-Campos Mayoral L, Romero-Tlalolini MLÁ, Jiménez-Martínez C, Arellanes-Robledo J, Villa-Treviño S, Vásquez-Garzón VR, Baltiérrez-Hoyos R. Chlorogenic acid attenuates idiopathic pulmonary fibrosis: An integrated analysis of network pharmacology, molecular docking, and experimental validation. Biochem BiophysRes Commun. 2024 Sep 7;734:150672. doi: 10.1016/j.bbrc.2024.150672. Factor de Impacto: 2.5
30. 2024: Aguirre-Maldonado I, Herrera-López EE, López-Zenteno F, Ramírez-Nava JC, López-Hernández NA, Arellanes-Robledo J, Del Pozo-Yauner L, García-Román R, Montero H, Alexander-Aguilera A, Noyola-Díaz JM, Camacho J, Pérez-Carreón JI. Intriguing hepatoprotective effects of sucrose on hepatocellular carcinoma pathogenesis. Sci Rep. 2024 Oct 10;14(1):23689. doi: 10.1038/s41598-024-74991-4. Factor de Impacto: 3.8

Circuito de Posgrado, Ciudad Universitaria
Alcaldía Coyoacán, C.P. 04510, México, CDMX

55 5623 7006
mdcbq@posgrado.unam.mx